Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Zhou, Wei-Pinga; 1 | Zan, Xing-Youb; 1 | Hu, Xiao-Yuna; 1 | Liu, Xiaoc | Sudarshan, Sanjeev Kumar Pitlad | Yang, Shu-Donge | Guo, Yu-Jiangc; * | Fang, Xiang-Minga; *
Affiliations: [a] Department of Radiology, Wuxi People’s Hospital, Nanjing Medical University, Jiangsu, China | [b] Department of Ultrasound, Wuxi People’s Hospital, Nanjing Medical University, Jiangsu, China | [c] Department of Thyroid Breast Surgery, Wuxi People’s Hospital, Nanjing Medical University, Jiangsu, China | [d] Department of Medical Imaging, Parexel International Corporation, Billerica, Massachusetts, USA | [e] Department of Pathology, Wuxi People’s Hospital, Nanjing Medical University, Jiangsu, China
Correspondence: [*] Corresponding authors: Xiang-Ming Fang, Department of Radiology, Wuxi People’s Hospital, Nanjing Medical University, Jiangsu, China. Tel.: +86 13861779030; E-mail: xiangming [email protected] and Yu-Jiang Guo, Department of Thyroid Breast Surgery, Wuxi People’s Hospital, Nanjing Medical University, Jiangsu, China. Tel.: +86 13358112052; E-mail: [email protected].
Note: [1] Co-author and contributed equally authors for the first author.
Abstract: OBJECTIVE:To investigate the characterization of breast lesions using diffusion kurtosis model-based imaging. METHODS:This prospective study included 120 consecutive patients underwent preoperative DCE-MRI examinations and multi-b-value diffusion-weighted imaging (DWI). Among them, 88 malignant lesions and 44 benign lesions were detected, 56 normal fibroglandular breast tissue were selected as normal control. Conventional apparent diffusion coefficient (ADC), DKI-based parameters mean kurtosis (MK) and mean diffusivity (MD) were analyzed by lesions types and histological subtypes using one-way ANOVA and receiver operating characteristic (ROC) curve. RESULTS:(1) The malignant group showed significantly lower ADC and MD (1.07±0.32×10-3 mm2/s and 1.30±0.40×10-3 mm2/s, respectively) and higher MK (0.87±0.18) than those in the benign group (1.29±0.26×10-3 mm2/s, 1.62±0.31×10-3 mm2/s and 0.67±0.18) and control group (1.67±0.33×10-3 mm2/s, 2.24±0.28×10-3 mm2/s and 0.52±0.08) with all P < 0.001. (2) Areas under ROC curve (AUC) for diagnosing malignant lesions were 0.936 for MD, 0.911 for MK and 0.897 for ADC, respectively. AUC for MD was significantly higher than that for ADC (P = 0.015). The optimal cut-off value, sensitivity, specificity, positive predictive value, negative predictive value and accuracy were as follow: ADC = 1.18×10-3mm2/s, 78.3%, 93.2%, 81.2%, 81.6%, 81.4%; MD = 1.48×10-3mm2/s, 82.2%, 98.3%, 84.4%, 87.8%, 86.2%; MK = 0.78, 91.5%, 85.3%, 89.0%, 85.8%, 87.2%. (3) Invasive ductal carcinoma (IDC), ductal carcinoma in situ (DCIS) and mucinous adenocarcinoma also showed significant differences among ADC, MD and MK (with P < 0.05). CONCLUSIONS:MR-DKI parameters enable to improve breast lesion characterization and have diagnostic potential applying to different pathological subtypes of breast cancers.
Keywords: Diffusion weighted imaging, diffusion kurtosis imaging, breast lesions, pathological subtypes
DOI: 10.3233/XST-190590
Journal: Journal of X-Ray Science and Technology, vol. 28, no. 1, pp. 157-169, 2020
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
[email protected]
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office [email protected]
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
如果您在出版方面需要帮助或有任何建, 件至: [email protected]